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Abstract
Introduction. Bisphenol A (BPA) is used in the chemical industry for manufacturing plastics which are used as 
food packaging. Data indicate that BPA is released from such products and is widely present in the environment 
and the human body. So far, the EFSA and the US FDA have determined “safe” BPA oral exposure levels, and 
a large amount of data indicates that BPA is harmful even at low-doses. Our previously performed analyses 
concerning BPA exposure demonstrated the impact of this substance on parasympathetic and peptidergic nerve 
fibers present within the liver. Therefore, this study concerns BPA exposure and sympathetic intrahepatic in-
nervation in reference to several neuropeptides which modulate neuronal responses: cocaine and amphetamine 
regulated transcript (CART), galanin (GAL), calcitonin gene-regulated peptide (CGRP) and substance P (SP). 
Materials and methods. Fifteen young swine at 8 weeks of age were used as experimental models of the juvenile 
human liver. The pigs were divided into 3 groups and received capsules orally with bisphenol at a dose of 0.05 
mg/kg b.w./day; a dose of 0.5 mg/kg b.w./day and placebo capsules as a control. After 28 days of oral BPA intake, 
the animals were euthanized, perfused with 4% paraformaldehyde (PFA), and livers were collected and fixed 
in PFA. The cryostat sections were subjected to a routine double-labeling immunofluorescence technique. The 
primary antibodies were directed against dopamine beta hydroxylase (DbH), which is a marker for sympathetic 
nerves, and one of the investigated neuropeptides: CART, GAL, CGRP and SP, which co-localized the inves-
tigated nerves. Immunoreactive nerves were counted in the liver and the percentage presence of each neuronal 
combination in particular samples of each experimental group were determined and analyzed statistically.
Results. The BPA oral intake at low and ten times higher dosage caused an increase of the number of sympa-
thetic nerve fibers within the porcine liver by 48.6% and 63.7%, respectively. Moreover, BPA exposure caused 
an increased presence of sympathetic nerve fibers in these two experimental groups, which were co-localized 
with CART and GAL up to 65.9%/173.2% and 147.4%/126.3%, respectively. At the lower BPA doses of 
50 μg/kg b.w./day, the percentages of SP+/DbH+ and CGRP+/DbH+ nerve fibers were similar to the control. 
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However at a ten times higher dose, BPA caused an increased number of SP+/ DbH+ and CGRP+/ DbH+ 
nerve fibers in the liver, up to 46.4% and 73.5% respectively. 
Conclusions. BPA caused an increase in the number of sympathetic nerve fibers as well as sympathetic nerve 
fibers which co-localized with neuropeptides in the porcine liver. The increase in CART and GAL were excep-
tionally high even at low BPA doses. BPA food contamination may dysregulate liver sympathetic innervation, 
and thereby may change the oxygenated blood supply, alter metabolism and disrupt the activity of hepatic pa-
renchymal cells. (Folia Histochemica et Cytobiologica 2018, Vol. 56, No. 2, 113–121)
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Introduction 
Bisphenol A (BPA) is an organic chemical compound 
with applications in the chemical industry for manu-
facturing many types of plastic which are mostly used 
as food packaging: household food containers, plastic 
water bottles and the lining of aluminum beverage 
cans [1]. A large amount of data indicates that BPA is 
released from plastic and polymer products because it 
is widely found in the environment: air, soil and water. 
Moreover BPA is also present in food, especially in 
cans, which most likely causes food exposure to BPA 
or its metabolites. This exposure has been reported 
in human serum, milk, urine and feces [2, 3].
BPA is considered to be an endocrine disrupting 
compound (EDC) because at the cellular level it acts 
as an agonist of a and b subtype estrogen receptors. 
It is significantly (1000–2000-fold) weaker than 17b 
estradiol, but acts similarly to estrogens causing a 
migration of the cytoplasmic receptor domain and 
activation of the estrogen nuclear receptor [4]. Plastic 
or polymer products with a BPA component were 
originally deemed to be safe, since they exhibit low 
concentrations of BPA. The European Food Safety 
Authority as well as the US Food and Drug Admin-
istration have determined BPA safe oral exposure 
levels to be below 4 μg/kg body weight/day and 5000 
μg/kg body weight/day, respectively [5, 6]. At the 
same time, the safety of the exposure level of this 
EDC has been extensively discussed and much data 
has shown that BPA is harmful even at low-doses 
[7, 8]. Experimental studies performed so far concerning 
BPA and its effect on the nervous system have mostly 
demonstrated its impact as disrupted sexual differenti-
ation and memory impairments, as well as changes in 
behavior such as hyperactivity and aggressiveness [9]. 
Moreover, a large amount of data has shown that BPA 
may not only change physiological processes in adults, 
but also could be destructive and cause alterations 
in nervous system development with accompanying 
morphological changes. In vitro, BPA significantly 
impairs the proliferation of neural progenitor cells 
and at high-doses it is even cytotoxic to them [10]. 
The in vivo experiments have demonstrated that BPA 
disrupts enteric innervation within particular parts of 
the porcine small intestine [11, 12]. 
Our previously performed analyses demonstrat-
ed the influence of BPA exposure on intrahepatic 
innervation components. Significant changes and 
increases in the number of parasympathetic and pep-
tidergic nerve fibers present within the liver have been 
correlated with high BPA dosage levels [13, 14]. To 
complete the series of experimental studies concern-
ing BPA and intrahepatic innervation, we decided to 
assess the potential changes of the sympathetic part 
of the autonomic nervous system with reference to 
several neuropeptides which modulate the neuronal 
response: cocaine- and amphetamine-regulated tran-
script (CART), galanin (GAL), calcitonin gene-regu-
lated peptide (CGRP) and substance P (SP). 
The assumption was made that experimental 
oral BPA exposure is similar to food BPA intake 
and could simulate BPA contamination in children 
and adolescents. The study describes the changes of 
intrahepatic innervation, because the small intestine 
digests food material and absorbs molecules which 
are transported directly to the liver through the 
hepatic portal vein. 
As in previous analyses, we used young swine at 
the age of 8 weeks as a potential model of the juvenile 
human liver. The anatomical and physiological sim-
ilarity between swine and human make the porcine 
liver one of the most useful experimental models for 
toxicological and pathophysiological studies [15, 16].
Using an innervated hepatic tissue to test ingested 
BPA exposure is reasonable since the liver is the first 
major organ exposed to dietary toxins. By testing 
alterations in the expression of nerve fibers in the 
liver, some suggestions concerning the impact of the 
above-mentioned alterations on liver function may be 
proposed. In this study we used an immunofloures-
cence technique to demonstrate the presence of 
dopamine beta hydroxylase (DbH), a marker specific 
for sympathetic nerve fibers, and four neuropeptides 
(CART, GAL, CGRP and SP) which can co-localize 
with DbH in the liver. 
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Materials and methods 
Animals and design of experiment. The study was performed 
on 15 Large White Polish juvenile female pigs at the initial 
age of 8 weeks and about 18–20 kg body weight (b.w.). Pigs 
were kept under typical laboratory conditions adapted for 
this animal species at the Faculty of Veterinary Medicine, 
University of Warmia and Mazury in Olsztyn (Poland). The 
experiment was performed according to the instructions of 
the Local Ethical Committee for Experiments on Animals 
in Olsztyn, decision number (28/2013).
After a 3-day adaptive period, the pigs were randomly 
divided into three experimental groups and received bisphe-
nol A (BPA) (cat. no. 239658, SigmaAldrich, St. Louis, MO, 
USA) or placebo in gelatin capsules for 28 days of feeding.
1) Control group — placebo (empty gelatin capsules);
2) Experimental group I — capsules with BPA at a dose 
of 0.05 mg/kg b.w./day;
3) Experimental group II — capsules with BPA at a dose 
10 times higher — 0.5 mg/kg b.w./day.
All animals were weighed in order to determine their 
body weight and calculate the proper dosage of BPA every 
four days before the morning feeding.
Tissue sampling. After 28 days of oral BPA intake, the 
animals were premedicated with azaperone (Stressnil, 
Janssen Pharmaceutica, Bruxelles, Belgium; 2.0 mg/kg body 
weight, i.m.). After about 30 min. the animals were eutha-
nized using an overdose of sodium thiopental intravenously 
(50 mg/kg b.w; Sandoz, Kundl-Rakúsko, Austria) and per-
fused transcardially with 4% buffered paraformaldehyde 
(PFA). Tissues were collected from all animals. Sections of 
liver tissue were fixed in the same PFA solution, rinsed in 
phosphate buffered saline (PBS, pH 7.4) for three days and 
kept in 18% sucrose at 4 °C. After two weeks, the tissue sam-
ples were frozen at −23°C and cut into 10 μm-thick sections 
using a microtome (Microm, HM 525, Walldorf, Germany). 
Immunofluorescent labeling and histomorphometry. 
The sections were subjected to a routine double-labeling 
immunofluorescence technique according to the method 
described previously by Wojtkiewicz et al. [16]. In short, 
overnight incubation was performed at 37oC with a mixture 
of two primary antibodies directed towards the dopamine 
beta hydroxylase (DbH) marker for sympathetic nerves and 
one of the studied neuropeptides: CART, GAL, CGRP or 
SP. The specification of primary and secondary antibodies 
which were used in the present study is presented in Table 1. 
Afterwards, the samples were incubated for 1 h (37oC) with 
species-specific antisera conjugated to FITC or biotin, which 
was visualized by streptavidin-CY3. 
During the present investigation, the standard controls for 
the specificity of “primary” antibodies were performed. These 
included pre-absorption of the particular antisera with ap-
propriate antigens, as well as “omission” and “replacement” 
tests that completely eliminated immunofluorescent signals.
Initially, the determination of the average number of 
DbH-positive nerve fibers per microscopic field of view 
Table 1. Primary and secondary antibodies used in this study
PRIMARY ANTIBODIES
Antisera Code Host species Dilution Supplier
DbH MAB 308 mouse 1:1000 Chemicon International Inc, UK; www.chemicon.com
CART H-003-61 rabbit 1:22000 Phoenix Europe
www.phoenixpeptide.com
GAL RIN7153 rabbit 1:10000 Peninsula Labs, US; see Bachem AG; www.bachem.com
CGRP 11189 rabbit 1:10000 MP Biomedicals; www.mpbio.com
SP 8450-0505 rabbit 1:10000 Biogenesis Inc, www.biogenesis.co.uk
SECONDARY ANTIBODIES
Dilution Supplier
Donkey anti-mouse IgG (H+L) conjugated 
with FITC
1:800 715-095-151; Jackson IR Lab, US; ww.jacksonimmuno.com
Biotinylated goat anti-rabbit immunoglobulins 1:1000 E0432, DAKO Corporation, US, www.dakousa.com
Biotin conjugated F(ab)’ fragment of affinity 
Purified anti-rabbit IgG (H+L) 
1:1000 711-1622, BioTrend, Germany; www.biotrend.com 
CY3- conjugated Streptavidin 1:9000 016-160-084, Jackson IR Lab, US; www.jacksonimmuno.com
Abbreviations: CART — cocaine- and amphetamine-regulated transcript; CGRP — calcitonin gene- regulated peptide; DbH — dopamine beta-hy-
droxylase; FITC — fluorescein isothiocyanate; GAL — galanin; SP — substance P. CY3- conjugated Streptavidin was used for detecting biotinylated 
antibodies (Cy3 excitation at 550 nm induces maximal emission at 570 nm).
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(0.1 mm2) was made. Nerve fibers were counted in five 
sections per animal (in five view fields per section). Subse-
quently, the number of DbH-LI nerve fibers which were im-
munoreactive with the other studied substances was counted. 
300 DbH immunoreactive nerve fibers in particular sections 
from each animal were counted for the presence of co-local-
ized neuropeptides, and these numbers were considered to 
represent 100% for each combination. This was performed in 
order to determine what percentages of DbH-positive nerve 
fibers were immunoreactive with CART, GAL, CGRP or SP. 
The measurements of the number of immunoreactive 
nerve fibers were performed by two investigators. Dou-
ble-labeled nerve fibers were visualized under an Olympus 
BX51 microscope (Olympus, Tokyo, Japan) equipped with 
epi-fluorescence and appropriate filter sets. To prevent 
double counting of the same nerve fibers, the evaluated 
sections were located at least 100 μm apart. 
Statistical analysis. The obtained results were pooled 
and presented as mean ± SEM. Statistical analysis was 
performed using Student’s t test (Graphpad Prism v. 6.0; 
GraphPad Software Inc., San Diego, CA, USA), and the dif-
ferences were considered statistically significant at p ≤ 0.05.
Results
BPA caused an increase of sympathetic  
nerve density within the liver
In comparison to the control group, there was a signif-
icant increase in the number of observed sympathetic 
nerves (DbH+), analyzed in the viewfield area, for the 
group of animals which were fed a BPA oral exposure 
at 0.05 mg/kg b.w/day, and the group which was fed 
0.5 mg/kg b.w./day; 48.6% and 63.7% respectively 
(Table 2, Fig. 1). 
BPA caused an increased presence of sympathetic 
nerves co-localized with the analyzed neuropeptides
CART/DbH immunoreactive nerve fibers, at an initial 
BPA oral exposure of 0.05 mg/kg b.w./day, were 65.9% 
more abundant than in the control, and statistically 
significant (Table 2, Fig. 1). At an exposure ten times 
higher, the CART/DbH immunoreactive nerve pres-
ence was 173.2% higher, in comparison to the control.
Furthermore at the low and high BPA dosage, 
the percentage of GAL/DbH immunoreactive nerve 
fibers was higher (147.4% and 126.3%, respectively) 
than in the control group (Table 2, Fig. 2). 
At a BPA oral intake of 0.05 mg/kg b.w./day, the 
percentages of SP+/ DbH+ and CGRP+/ DbH+ 
nerve fibers were similar to the control. However 
at a ten times higher exposure level, the expression 
of SP+/DbH+ was 46.4% and CGRP+/DbH+ was 
73.5% higher than in the control group (Table 2, Fig. 
3, 4, statistically significant, p ≤ 0.05).
The results reported above are presented in Table 2 
and representative images of the immunocytochemi-
cal co-localization of DbH with the chosen neuronal 
markers are shown in Figures 1–4. 
Discussion 
Anatomical studies have described that porcine liver 
in the portal area and in the parenchyma is innervated 
by abundant nerve fibers of the autonomic nervous 
system [18]. In the portal triad, the sympathetic nerves 
innervate the interlobular branches of the hepatic 
artery, portal vein and the bile duct. In the hepatic 
parenchyma, the sympathetic nerve fibers run from 
the portal area, and their terminal is in close vicinity to 
hepatocytes as well as other cells located in this area 
[18]. Comparison among higher mammalian species 
such as pig, dog, monkey and human demonstrate a 
high anatomic resemblance in the hepatic innervation 
between them [18, 19]. 
The results of this study show an increase in the 
presence of DbH immunoreactive nerve fibers and 
this is comparable to our previous analyses which 
have also demonstrated an overexpression of para-
sympathetic and peptidinergic nerves fibers within 
porcine liver after BPA oral intake [13, 14]. Such 
results suggest that BPA food contamination may 
disrupt proper innervation and balance between main 
components of the autonomic nervous system within 
liver. It could be assumed that sympathetic nerve 
fiber overexpression may cause improper blood flow 
within the portal area due to potential constriction 
of the interlobular artery. Similarly, within hepatic 
parenchyma such an increase of innervation may 
impair blood supply within the sinusoidal area and 
also could have an impact on hepatocyte metabolism; 
the activity of Kupffer cells and hepatic stellate cells 
[20]. Sympathetic regulation within the parenchyma 
of hepatic lobules is not only involved with the regu-
lation of liver physiology, but it could also be related 
with several pathophysiological processes such as 
liver repair and regeneration [21]. 
Our results also show an increase in DbH nerves 
which were co-localized with SP and CGRP neuropep-
tides in response to BPA exposure in a dose related 
manner. It is known that SP- and CGRP-immunore-
active (IR) nerve fibers have an afferent course to the 
spinal sensory ganglia and have sensory function in the 
alimentary tract and its glands [22, 23]. Comparative 
anatomical studies concerning SP nerve fibers have 
been conducted in many species including human 
but not in porcine. These studies have demonstrated 
numerous SP immunoreactive nerve fibers, which are 
present around the interlobular veins and arteries, 
with a lack of such innervation around the interlobular 
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bile duct. Furthermore, SP-IR nerve fibers are also 
observed in the hepatic parenchyma. So far, these 
have been classified as peptidergic nerve fibers [19]. 
Our previous studies, as well as the study presented 
above, have shown that SP neuropeptide within the 
porcine liver is colocalized with parasympathetic 
and sympathetic nerve fibers as well as nerve fibers 
alone [13, 14] Other data have demonstrated that 
SP-IR nerves fibers could cause vasodilation and 
modulate microcirculation in hepatic sinusoids [20]. 
The CGRP-IR nerve fibers innervate the interlobular 
artery and bile duct; however, they are not present in 
the intralobular region of animal and human liver [19]. 
Other data concerned with skin innervation and inter-
nal microcirculation demonstrate that SP and CGRP 
are simultaneously released from sensory fibers and 
could cause short- and long-term vasodilation and 
plasma extravasation [24]. On the basis of the results 
of our study, it might be suspected that dose related 
BPA exposure changes the normal pattern of hepatic 
Table 2. Neurochemical characteristics and changes in neuropeptide expression in porcine intrahepatic sympathetic nerves 
under physiological conditions and after bisphenol A (BPA) administration. Nerve fibers were counted in five sections per 
animal (in five view fields per section). *These results are statistically significant at p ≤ 0.05
Neurochemical characteristic of fibers Experimental group
Control Low-dose BPA High-dose BPA
DbH + 21.2 ± 2.08 31.5 ± 1.85* 34.7 ± 1.61*
DbH +/CART+ 8.2 ± 1.65 13.6 ± 1.57* 22.4 ± 3.26*
DbH +/GAL+ 3.8 ± 0.96 9.4 ± 2.01* 8.6 ± 1.57*
DbH +/CGRP+ 9.8 ± 1.59 10.6 ± 1.77 17.0 ± 2.81*
DbH +/SP+ 5.6 ± 1.63 6.2 ± 1.88 8.2 ± 1.98*
Abbreviations: BPA — bisphenol A; C — control animals; E1 — low-dose BPA group, 0.05 mg/kg b.w./day for 28 days); E2 — high dose BPA group 
(0.5 mg/kg b.w./ day for 28 days)
Figure 1. Representative images of immunofluorescent detection of DbH-, and CART-immunoreactive nerve fibers in the 
livers of control pigs (I) or pigs exposed to low (II) or high doses (III) of bisphenol A, as described in Methods. DbH- or 
CART-immunoreactive (IR) nerve fibers are indicated with arrows, DbH- and CART-IR nerve fibers are indicated with 
double-headed arrows. Scale bars in all figures: 20 μm. 
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Figure 2. Representative images of immunofluorescent detection of DbH- and GAL-immunoreactive nerve fibers in the 
livers of control pigs (I) or pigs exposed to low (II) or high doses (III) of bisphenol A, as described in Methods. DbH- or 
GAL-immunoreactive (IR) nerve fibers are indicated with arrows, DbH- and GAL-IR nerve fibers are indicated with dou-
ble-headed arrows. Scale bars in all figures: 20 μm.
Figure 3. Representative images of immunofluorescent detection of DbH- and CGRP-immunoreactive nerve fibers in the 
livers of control pigs (I) or pigs exposed to low (II) or high doses (III) of bisphenol A, as described in Methods. DbH- or 
CGRP-immunoreactive (IR) nerve fibers are indicated with arrows, DbH- and CGRP-IR nerve fibers are indicated with 
double-headed arrows. Scale bars in all figures: 20 μm.
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innervation, which could disturb blood and bile flow 
in the portal area and microcirculation within hepatic 
sinusoids.
So far, BPA is considered to be an endocrine dis-
rupting compound which reacts with nuclear estrogen 
receptor [4]. Moreover, it has also been described that 
BPA could react with membrane epithelial growth 
factor receptor (EGFR) and via ERK1/2 and AKT 
signaling pathways. This could activate cellular growth 
and cell proliferation; especially in cancer cells [2]. 
Nevertheless, there is a lack of experimental data 
which could directly demonstrate how BPA could 
impair the components of the peripheral nervous 
system. There is much data concerned with brain 
physiology and the impact of BPA exposure which 
causes disruptive patterns of behavior [9]. 
Another result of our study clearly demonstrates 
the presence of sympathetic nerves which are co-lo-
calized with galanin in porcine liver. The distribution 
of such nerves in this organ has not been clearly ev-
idenced, so far. Our results show an increase in the 
density of immunoreactive DbH+ /GAL+ nerve fibers, 
and this alteration was visible even at low BPA doses. 
Data from the literature indicate that current in-vitro 
studies are mostly concerned with different hormone 
dependent cells but not with hepatocytic cell cultures. 
These experiments demonstrate the impact of BPA 
on estrogen receptor up-regulation which causes cell 
activation and cell proliferation even at very low BPA 
concentrations [8]. Other data show galanin co-lo-
calization in sympathetic nerve fibers, but this was 
performed in dog liver. Most likely, galanin in these 
nerves acts as a neuromodulator and has a potential 
role in hepatic glucose release [25, 26].
The results of our study also demonstrate a signif-
icant increase in the presence of sympathetic nerve 
fibers which were co-localized with CART within 
the liver. Although CART is widely present within 
the enteric innervation of the alimentary tract, the 
exact function of this neuropeptide still seems to be 
unclear. It is possible that CART within the enteric 
neurons fulfils a neuroprotective role [27]. Howev-
er, the widespread presence of CART in intestinal 
innervation more likely suggests that CART could 
be a modulator of motility and secretion within the 
alimentary tract [28, 29]. It should be emphasized 
that CART co-expression within sympathetic nerve 
fibers in mammalian liver has been demonstrated 
for the first time. Furthermore, a distinct increase of 
CART immunoreactive nerve fibers caused by BPA 
Figure 4. Representative images of immunofluorescent detection of DbH- and SP-immunoreactive nerve fibers in the livers 
of control pigs (I) or pigs exposed to low (II) or high doses (III) of bisphenol A. as described in Methods. DbH- or SP-im-
munoreactive (IR) nerve fibers are indicated with arrows, DbH- and SP-IR nerve fibers are indicated with double-headed 
arrows. Scale bars in all figures: 20 μm.
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exposure even at low doses is worth underlining. It is 
known that CART is not only a neurotransmitter in 
the central nervous or autonomic nervous system, but 
CART most likely plays a role as a hormone, because 
this presence has been documented in the endocrine 
cells of the adrenal medulla and the C-cells of the 
thyroid gland [30].
In summary, it should be highlighted that each 
neuropeptide that was studied demonstrated 
increased levels of expression within the sympa-
thetic nerves of hepatic tissue. The increase of 
the density of CART- and GAL-IR sympathetic 
nerve fibers was high even at low BPA doses. DbH 
expression was also increased, which indicates an 
over-activation of the sympathetic nervous system. 
Compiling the results of our studies with previously 
performed analyses concerning BPA exposure and 
the parasympathetic and peptidinergic parts of liver 
innervation [13, 14]; we come to the conclusion that 
BPA causes a general dysregulation of nerve fibers. 
This evidence indicates that BPA exposure even at 
recommended safe levels is still far too high. Fur-
thermore, it is hoped that this study may be an early 
step in the determination of linking BPA exposure 
to pathological disease states. 
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